The rising rate of overweight and obesity is a public health crisis in the United States and increasingly around the globe. Rates of contraceptive use are similar among women of all weights, but because contraceptive development studies historically excluded women over 130% of ideal body weight, patients and providers have a gap in understanding of contraceptive efficacy for obese and overweigh...

BACKGROUND AND METHODOLOGY Giving young women access to newer contraceptives such as the combined contraceptive patch, combined contraceptive vaginal ring and single-rod implant may help reduce teenage pregnancies. However, little is known about young people's attitudes towards these contraceptives. This cross-sectional survey, using a self-completion questionnaire, aimed to explore young peopl...

CONTEXT Publicly funded family planning agencies face significant challenges in delivering quality services to low-income women because of the higher costs of newer contraceptive methods, changes in health care financing and a growing uninsured population. METHODS In 2003, 627 of a nationally representative sample of 956 U.S. agencies receiving public funding for family planning services resp...

OBJECTIVE To determine the relative bioavailability of ethinyl estradiol (EE) and gestodene (GSD) after application of a novel transdermal contraceptive patch vs. a standard combined oral contraceptive (COC) pill (study 1), and to evaluate the pharmacokinetics (PK) of EE after application of the EE/GSD patch compared with an EE/norelgestromin (NGMN) patch (study 2). MATERIALS Participants wer...

OBJECTIVE This report presents national estimates of contraceptive use and method choice based on the 1982, 1995, 2002, and 2006-2008 National Surveys of Family Growth (NSFG). METHODS Data for 2006-2008 were collected through in-person interviews with 13,495 men and women 15-44 years of age in the household population of the United States. This report is based on the sample of 7,356 women int...

IMPORTANCE Isotretinoin, a known teratogen, is strictly regulated through the iPLEDGE program. However, isotretinoin-exposed pregnancies continue to occur. OBJECTIVE To evaluate an information sheet's effect on women's contraceptive knowledge. DESIGN, SETTING, AND PARTICIPANTS Women aged 18 to 45 years visiting a dermatology practice completed anonymous surveys assessing their knowledge of ...

objective: the world population will likely increase by 2.5 billion over the next 43 years, passing from the current 6.7 billion to 9.2 billion in 2050. only limited information about the contraceptive practices especially modern contraceptive use is available. the aim of this study is to determine the prevalence of contraceptive methods and factors associated with modern contraceptive in use m...

O’Brien et al. (1) must be commended for evaluating the risk of thromboembolism among women with type 1 or 2 diabetes using hormonal contraception. Indeed, their study is robust and the drug safety issue too frequently overlooked. However, their conclusion that “the absolute risk of thromboembolism among women with type 1 or 2 diabetes using hormonal contraception is low” deserves comment as am...